Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillance.

Microbial genomics - 1 Mar 2025

Lule Daniel Bugembe, Ssemwanga Deogratius, Kaleebu Pontiano, Tully Damien C

Abstract excerpt

HIV continues to be a significant global public health concern. In 2022, an estimated 29.8 million people living with HIV received antiretroviral treatment (ART). From this, an estimated 10-15% of individuals living with HIV have drug-resistant strains of the virus. Testing for resistance to antiretroviral drugs is recommended before initiating ART. However, such services are often inaccessible due to costs and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to HIV Infections

Share to Mutation

Share to Nanopore Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 40111248
DOI: 10.1099/mgen.0.001375
PMCID: PMC11925199

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 16 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillance.PMID 40111248Read ↗

Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations.Semantic proximity Read ↗

Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunity.Semantic proximity Read ↗

Portable Nanopore sequencing solution for next-generation HIV drug resistance testing.Semantic proximity Read ↗

HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.Semantic proximity Read ↗

Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.Semantic proximity Read ↗

HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance PipelineSemantic proximity Read ↗

HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance PipelineSemantic proximity Read ↗

Deep sequencing for HIV-1 clinical management.Semantic proximity Read ↗

Barcoding analysis of HIV drug resistance mutations using Oxford Nanopore MinION (ONT) sequencingSemantic proximity Read ↗

Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing.Semantic proximity Read ↗

Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.